Gene Query: RICTOR

Dataset Description Geneva Score
The regulartory role of ZCCHC24 in splicing machinery 45.29
RNA transcriptome sequencing analysis of SGC-7901 cells transfected with ENST00000431060 shRNA or control shRNA 32.33
An RNA-centric dissection of host complexes controlling flavivirus infection 31.35
An RNA-centric dissection of host complexes controlling flavivirus infection [RNA-Seq] 31.35
Differential analysis of gene regulation at transcript resolution by RNA-Seq 31.13
Differential analysis of HOXA1 in adult cells at isoform resolution by RNA-Seq [Illumina] 31.13
RNA-seq of cancer-associated fibroblasts (CAF) treated with PBS or extracellular vesicles (EV) from MCF10A or MDA-MB-231 cells 31.12
DNA methylation state is associated with the formation of loops and links in hematopoietic stem cells 30.67
DNA methylation state is associated with the formation of loops and links in hematopoietic stem cells [RNA-seq] 30.67
Transcriptome profiling of influenza virus-infected human bronchial epithelial cells 30.18
The contribution of Alu exons to the human proteome 28.27
A Hybrid Mechanism of Action for BCL6 in B Cells Defined by Formation of Functionally Distinct Complexes at Enhancers and Promoters 28.17
Global gene expression profiling from LeuCAG3'tsRNA depleted- HeLa and HCT-116 cell lines through 50 base pair paired-end RNA-seq 27.68
A novel P300 inhibitor reverses DUX4-mediated global histone H3 hyperacetylation, target gene expression and cell death 27.42
RNA-seq in neutrophils from Juvenile Idiopathic Arthritis 27.21
Transcriptomic analysis of differential expressed genes of human tonsillar epithelial cells UT-SCC-60B in response to EV71 infection 25.39
Polyol pathway links glucose metabolism to the aggressiveness of cancer cells 23.96
Antibody-Mediated Inhibition of MICA/B Shedding Promotes NK Cell-Driven Tumor Immunity 23.68
VAMP8 contributes to TRIM6-mediated type-I interferon antiviral response upon West Nile virus (WNV) infection 23.17
Genome-wide MAF1-dependent regulation of RNA polymerase III transcription [RNA-Seq] 23.13
Genome-wide MAF1-dependent regulation of RNA polymerase III transcription 23.13
Global analysis of pre-mRNA subcellular localization upon splicing inhibition by spliceostatin A 21.14
Genes significantly down or Up-regulated upon RNF219 knockdown 21.13
DUX4 recruits p300/CBP through its C-terminus and induces global H3K27 acetylation changes 20.82
Trnascriptome analysis of HeLa cells infected with rTHOV-wt, -dML, -SW mutant or mock-treated 20.54
Non-synchronized cell cycle transcriptomics in U2OS and HeLa cancer cells 20.19
GREB1, a novel target of Wnt signaling, promotes development of hepatoblastoma by suppressing TGFβ signaling 20.15
A Brain Penetrant Mutant IDH1 Inhibitor Provides In Vivo Survival Benefit 20.02
Knockout human reveal an essential role for Paternally Expressed 10 (PEG10) in JEG3 cell line development 19.87
Transcriptome sequencing wide functional analysis of human mesenchymal stem cells with PolyIC treatment 19.74
Impact of dieldrin on transcription in Jurkat T cells 19.7
Inhibitors of the histone methyltransferases EZH2/1 induce a potent antiviral state and suppress infection by diverse viral pathogens [RNA-Seq] 19.19
Inhibitors of the histone methyltransferases EZH2/1 induce a potent antiviral state and suppress infection by diverse viral pathogens 19.19
Transcription profile analysis of wild type and Irf9-/- human monocytic THP1 cells in response to type I interferons 18.56
Irf9 function in immunity in mouse 18.56
Opposing Effects of Cyclooxygenase-2 (COX-2) on Estrogen Receptor β (ERβ) Response to 5α-reductase Inhibition in Prostate Epithelial Cells 18.52
High-throughput sequencing of PROMPT-enriched samples. 18.05
Gene expression profiling of human CD19+ B cells and EBV transformed lymphoblastoid cell lines (LCLs) 18.0
Bioinformatics analysis of transcriptome related to blood stasis syndrome in diabetes mellitus patients 17.97
TALENs-mediated gene disruption of FLT3 in leukemia cells: Using genome-editing approach for exploring the molecular basis of gene abnormality 17.78
Multivalent binding of PWWP2A to H2A.Z-marked transcriptional active chromatin regulates mitosis and organ development 17.73
Multivalent binding of PWWP2A to H2A.Z-marked transcriptional active chromatin regulates mitosis and organ development [RNA-seq] 17.73
HOXC6 affects the malignant phenotype of esophageal squamous cell carcinoma cells 17.68
RNA sequencing of matched nephrectomy samples [RNA-seq] 17.57
Genome-wide maps of H3K36me3 in ccRCC and RNA-seq of matched nephrectomy samples 17.57
Transcriptome of human keratinocytes with or without HPV16 oncogene expression 17.52
MOF acetyl transferase regulates transcription and respiration in mitochondria 17.29
TGF-β regulation of miRNA expression in pancreatic cancer 17.16
Differential expression of long non‑coding RNA and mRNA in children with Henoch‑Schönlein purpura nephritis 16.62
Che-1 is targeted by c-Myc to sustain proliferation in pre-B-cell acute lymphoblastic leukemia 16.59
Che-1 is targeted by c-Myc to sustain proliferation in pre-B-cell acute lymphoblastic leukemia [RNA-seq] 16.59
The ARID1A tumor suppressor controls global transcription via pausing of RNA Polymerase II 16.49
Expression profiling by high throughput sequencing of tumors derived from human prostate epithelial cells transformed with the oncogenes N-Myc and myrAKT1. 16.46
Identification of IL-27 as potent regulator of inflammatory osteolysis associated with vitamin E-blended ultra-high molecular weight polyethylene debris of orthopedic implants 16.42
Treatment Paradigms for Retinal and Macular Diseases Using 3-D Retina Cultures Derived From Human Reporter Pluripotent Stem Cell Lines 16.39
Tyrosine Kinase Inhibitor Cardiotoxicity 16.28
High-Throughput Screening of Human Induced Pluripotent Stem Cell Cardiomyocytes Predicts Tyrosine Kinase Inhibitor Cardiotoxicity 16.28
R430: A potent inbibitor of DNA and RNA viruses 16.23
Integrated analysis of MLL-AF9 AML patients and model leukemias highlights RET and other novel therapeutic targets (RNA-seq B-ALL) 16.04
Transcriptomics analysis of gene expression in multiple human and mouse cells and tissues 15.88
The Role of Histone H3 Lysine 36 Methylation in Reprogramming of fibroblasts and on Induced Pluripotent stem Cell Generation 15.84
Genome-wide analysis of ferroptosis related genes in liver cancer cells. 15.77
The effect of Abl kinases,or Ponatinib challenging on breast cancer cells' global transcriptome 15.45
Leukodystrophy-associated POLR3A mutations down-regulate the RNA polymerase III transcript and important regulatory RNA BC200 14.89
RNA-seq of resting and activated CD4+ T cells +-JQ1 14.62
Genomic expression analysis of K562 cells expressing shRNA targeting lncRNA-IIRX and control cells 14.6
Exogenous pyruvate represses histone gene expression to inhibit cancer cell proliferation via the NAMPT-NAD + -SIRT1 pathway 14.58
Global Regulation of Alternative Internal Exon Usage by mRNA 3' End Formation Factors [RNA-Seq] 14.49
Global Promotion of Alternative Internal Exon Usage by mRNA 3' End Formation Factors 14.49
Identification of Nrf2 regulated genes by RNA sequencing 14.42
Nrf2 regulated genes in A549 cells 14.42
Gene expression profile of HGC27 and LMSU gastric cancer cell p53 KO and KD 14.39
Evidence for rRNA 2'-O-methylation plasticity: control of intrinsic translational capabilities of human ribosomes 14.37
Limiting cholesterol biosynthetic flux engages type I IFN signaling in a STING-dependent manner 14.17
Apatinib preferentially inhibits Gefitinib-resistant lung cancer cells by inducing cell cycle arrest and inhibiting VEGFR signaling pathway 13.92
Nuclear receptor RORγ is a targetable master regulator of cholesterol in a subtype of breast cancer 13.91
siRNA-mediated silencing of ORAI3 in MDA-MB-468 breast cancer cells exposed to hypoxia 13.89
UV-Irradiation Induces a Noncoding RNA that Functionally Opposes the Protein Encoded by the Same Gene 13.85
Gene expression, methylome and splicing of THP-1 monocytic cells and THP-1-derived macrophage 13.82
Gene expression in PANC1 cells treated with Rakicidin 13.7
RNA-sequencing time course of Human Intestinal Epithelial Cells (HIECs) following knockdown of miR-30bcd using complementary locked nucleic acids 13.66
Developmental origins define epigenomic differences between subcutaneous and visceral adipocytes 13.62
The ETS transcription factor ELF1 regulates a critical, broadly antiviral program distinct from the type I interferon response 13.61
The ETS transcription factor ELF1 regulates a critical, broadly antiviral program distinct from the type I interferon response 13.61
High capacity of the endoplasmic reticulum to prevent secretion and aggregation of amyloidgenic proteins 13.61
Effect of BRCA1 overexpression on genetic expressions of cervical cancer based on next generation sequencing 13.53
Expression profile and potential functions of circulating long noncoding RNAs in acute ischemic stroke in the Southern Chinese Han population 13.48
Enhancer Sequence Variants and Transcription Factor Deregulation Synergize to Construct Pathogenic Regulatory Circuits in B Cell Lymphoma 13.46
Enhancer Sequence Variants and Transcription Factor Deregulation Synergize to Construct Pathogenic Regulatory Circuits in B Cell Lymphoma (RNA-Seq) 13.46
Nuclear receptor RORγ is a targetable master regulator of cholesterol in a subtype of breast cancer [RNA-Seq] 13.41
Gene expression profile of LMSU gastric cancer cell p53 KO and KD 13.38
The effect of slow and rapid H2S production on the levels of LPS-induced proinflammatory mediators and transcription in different human cell cultures 13.31
Gene expression analysis of dengue-infected cells 13.16
Genome wide expression change by RNF168 knocking down in NEC cells 13.07
Widespread backtracking by RNA pol II is a major effector of gene activation, 5’ pause release, termination and transcription elongation rate 12.89
Codon usage optimization in pluripotent embryonic stem cells [RNA-seq] 12.88
Hierarchy of mono- and bi-allelic TP53 alterations in Multiple Myeloma cell fitness 12.76
RNASEQ Analysis of sh-TRC and sh-MIR100HG in the triplex negative breast cancer 12.73
Heterozygous p53-R280T mutation promotes proliferation of NPC cells through activating PI3K/Akt signaling pathway 12.57
RNA-seq of cultured human kidney peritubular microvascular endothelial cells following exposure to cyclosporine A 12.51
LncRNA-GAS5 negative regulation of YAP-target genes expression 12.5
Distinct epigenomes in CD4+ T cells of newborns, middle-ages and centenarians. 12.47
SMN2 splicing modifiers improve motor function and longevity in mice with spinal muscular atrophy 12.45
RNA-seq in acute myeloid leukemia (AML) cells with and without knockdown of METTL14 12.42
Understanding the Mechanistic Contribution of Herbal Extracts in Compound Kushen Injection with Transcriptome Analysis 12.32
Mitochondrial phosphoenolpyruvate carboxykinase (PCK2) regulates metabolic adaptation and glucose-independent tumor cell growth 12.29
Discovery of naturally occurring ESR1 mutations during acquisition of resistance to endocrine therapy in widely used estrogen receptor positive breast cancer cell lines 12.2
Discovery of naturally occurring ESR1 mutations during acquisition of resistance to endocrine therapy in widely used estrogen receptor positive breast cancer cell lines [RNA-Seq] 12.2
Comparative Analysis of the Transcriptome of Latent Autoimmune Diabetes (LADA) Patients from Eastern China 12.09
High-Throughput Kinetic Analysis of Fractional Killing 12.07
Gene expression by high-throughput sequencing of T47D-MTVL human breast cancer cells upon H1.4 knock-down and multiple H1 variants 11.99
Insulin receptor associates with promoters genome-wide and regulates gene expression [RNA-seq] 11.98
Aging Human Hematopoietic Stem Cells Manifest Profound Epigenetic Reprogramming of Enhancers That May Predispose to Leukemia (RNA-Seq of LMNA KD) 11.97
Characterization of transcriptomics landscape in HUVEC cells exposed to oxidative stress (Total RNA) 11.94
Silencing SPIB in attached and floating state of H1703 lung cancer cells 11.88
The NFkB subunit RELA is a master transcriptional regulator of the committed epithelial-mesenchymal transition in airway epithelial cells 11.82
A cytoplasmic COMPASS is necessary for cell survival and triple-negative breast cancer pathogenesis by regulating metabolism 11.76
MeRIP sequencing reveals angiogenic properties of vascular endothelial cells 11.67
RNA-seq of ASXL2 shRNA KD in SKNO-1 cells 11.66
RNAseq to determine gene expression changes following depletion of SETDB1 in THP-1 AML Cells 11.65
Differential gene expressions in the heart of hypertrophic cardiomyopathy patients 11.65
Transcriptome sequencing wide functional analysis of human mesenchymal stem cells 11.57
Messenger RNA expression after silencing or inhibition of MEN1in MCF-7 breast cancer cells 11.53
RNAseq Analysis in glioblastoma cells treated with Mepazine 11.51
Gene expression data from IMR90 control, IMR90 shRRM2 and shRRM2/shp16 11.42
RNA-sequencing (RNA-seq) in BxPC-3 and S2-007 cell lines 11.35
H3K27Ac in MCF7 Y537S ER mutant cells and RNAseq with and without treatment with THZ1 11.28
RNA sequencing to study transcriptomic changes in DLD-1 (colorectal adenocarcinoma) cells exposed to soft polyacrylamide matrices (~2 kPa and ~55 kPa) for short time scale of 90 minutes 11.26
RNASeq of mouse, human, and non-human primate primary dermal fibroblasts to poly(I:C) transfection 10.98
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells 10.9
Transcriptomic profiling of human HAP1 cells before and after nutrient deprivation 10.9
Human HAP1 cells before and after nutrient deprivation 10.9
Disease modelling of core pre-mRNA splicing factor haploinsufficiency 10.86
NET-CAGE Characterizes the Dynamics and Topology of Human Transcribed Cis-regulatory Elements 10.85
Capturing the Interactome of Newly Transcribed RNA 10.84
Capturing the Interactome of Newly Transcribed RNA (RICK) 10.84
Dual inhibition of HDMX and HDM2 as a Therapeutic Strategy in Leukemia 10.8
Ex vivo expanded human 3D Nephrospheres engraft long term and repair chronic renal injury in mice 10.73
Profiling of circular RNAs in gastric cancer tissues and adjacent normal tissues 10.72
RNA sequencing of heart samples of myotonic dystrophic (DM1) patients 10.65
Selectively targeting bromodomain and extraterminal proteins for degradation as a novel anti-glioblastoma strategy [RNA-seq] 10.63
Insulin induced alterations in chromatin acetylation and transcriptome in triple negative breast cancer cells 10.63
RNA-seq from control and macroH2A1-depleted IMR90 primary human lung fibroblasts 10.62
Exploring the role of macroH2A1 in transcription regulation in IMR90 primary human lung fibroblasts with RNA-seq and ChIP-seq 10.62
Next Generation Sequencing Facilitates Quantitative Analysis of Health donors and SLE patients' PBMC Transcriptomes 10.59
Expression data from human perivascular stem cell-derived extracellular vesicles (PSC-EVs) and PSCs 10.59
Three-dimensional Oxabicycloheptene sulfonate targets the homologous recombination and repair programs through estrogen receptor α antagonism 10.57
Transcriptome analysis in Neobractatin treated cells 10.57
RNA-seq expression data from FL-HSPCs after HOXA7 knockdown 10.46
Model systems of DUX4 expression recapitulate the transcriptional profile of FSHD cells 10.42
The stress granule transcriptome reveals principles of mRNA accumulation in stress granules. 10.38
Cohesin and CTCF Differentially Affect the Chromatin Architecture and Gene Expression in Human Cells 10.37
Ribosomal footprinting of MDA-Parental and MDA-LM2 10.35
Evolving Spindlin1 Small Molecule Inhibitors Using Protein Microarrays 10.3
Global Bidirectional Transcription of the Epstein-Barr Virus Genome During Reactivation 10.29
Whole-transcriptome profilings between a pair of HCA7-derived KRAS-wildtype cetuximab sensitive and resistant colon cancer cells from 3D culture 10.27
Single cell RNA sequencing reveals microglia-like cells in cerebrospinal fluid  during virologically suppressed HIV 10.19
Regulation of poly(A) tail and translation during the somatic cell cycle 10.19
Human cell line and subcutaneous tumor 10.17
Expanding the Nucleoside Recoding Toolkit: Revealing RNA Population Dynamics with 6-thioguanisine 10.15
Alu RNA modulates the expression of cell cycle genes in human fibroblasts 10.14
LINC00520 is Induced by Src, STAT3, and PI3K and Plays a Functional Role in Breast Cancer 10.08
Benzotriazoles reactivate latent HIV-1 through inactivation of STAT5 SUMOylation 10.06
Benzotriazoles reactivate latent HIV-1 through inactivation of STAT5 SUMOylation (RNA-Seq) 10.06
Integrative transcriptome-wide analyses reveal critical HER2-regulated mRNAs and lincRNAs in HER2+ breast cancer 9.94
Mining the stiffness-sensitive transcriptome in human vascular smooth muscle cells identifies long non-coding RNA stiffness regulators 9.93
Ribosomal footprinting of MDA_Ctrl and MDA_Arg overexpression cell lines 9.92
Distinct regulatory programs for Sox9 in transcriptional regulation of the developing mammalian chondrocyte 9.88
Distinct regulatory programs for Sox9 in transcriptional regulation of the developing mammalian chondrocyte [RNA-seq] 9.88
An epigenetic mark of polycomb response elements implemented by Trx/MLL/COMPASS 9.84
Plasma cell mitochondrial pyruvate import controls the duration of humoral immunity. 9.82
Exploring ILF2 regulatory genes by next-generation sequencing 9.79
RNA-seq analysis to identify the genes regulated by p53-SET interplay 9.79
MULTI-seq: Universal sample multiplexing for single-cell RNA sequencing using lipid-tagged indices 9.78
Expression and functions of long noncoding RNAs during human T helper cell differentiation 9.78
Interactions of aCPs with Cytosine-rich Polypyrimidine Tracts Enhance Splicing of Cassette Exons 9.73
RNA-dependent RNA polymerase sequence specificities of capsnatching viruses are tailored to aid viral replication 9.72
Toxoplasma gondii infection of human retinal pigment epithelial cells 9.7
Dual role of CSL (RBP-Jk) and NOTCH1 in CAF 9.69
Dual role of CSL (RBP-Jk) and NOTCH1 in cancer-associated fibroblast genome stability and expansion [RNA-seq] 9.69
Characterization of gene regulation and protein interaction networks for Matrin 3 encoding mutations linked to amyotrophic lateral sclerosis and myopathy 9.66
A critical but divergent role of PRDM14 in human primordial germ cell fate revealed by inducible degrons 9.61
A critical but divergent role of PRDM14 in human primordial germ cell fate revealed by inducible degrons [RNA-seq] 9.61
Subcellular RNA fractions of HSV-1 infected primary human fibroblasts 9.5
RNA sequencing of erythroid and granulomonocytic colonies differentiated from transduced bone marrow CD34+ cells expressing U2AF1 S34F mutation, U2AF1 wild-type or empty vector control 9.44
RNA-seq Profiles in Transcription elongation factors are in vivo-specific cancer dependencies in glioma 9.43
Transcription elongation factors are in vivo-specific cancer dependencies in glioma 9.43
Transcriptome of diurnal human blood neutrophils 9.42
EWSR1 influences alternative splicing through direct and indirect mechanisms 9.34
Profiling of protrusion-enriched RNAs from human breast cancer cell line MDA-MB-231 9.22
Comprehensive molecular phenotypic effects of the large deletion on chromosome 22q11.2 9.19
Genome-wide maps in MCF-7 cells with six2 or CYP4Z1 3'UTR or CYP4Z2P 3'UTR overexpression or not 9.16
TRIM28-Regulated Transposon Repression Is Required for Human Germline Competency and Not Primed or Naive Human Pluripotency 9.09
Targeting MTHFD2 in Acute Myeloid Leukemia 9.01
RNA-sequencing based transcriptome-wide expression profiling of Cynomolgus monkey and human IPSCs in vitro differentiated into endothelial cells 9.01
Apolipoprotein E4 Expression Causes Gain of Toxic Function in Isogenic Human Induced Pluripotent Stem Cell-Derived Endothelial Cells 8.98
Programmable RNA N6-methyladenosine editing by CRISPR-Cas9 conjugates 8.95
MKL1 augments megakaryocyte maturation by enhancing the SRF regulatory axis [RNA-seq] 8.92
MKL1 augments megakaryocyte maturation by enhancing the SRF regulatory axis 8.92
Transcriptional regulation of autophagy-lysosomal function in BRAF-driven melanoma progression and chemoresistance 8.82
DHX9 suppresses spurious RNA processing defects originating from the Alu invasion of the human genome [uvCLAP CLIP-seq] 8.82
Be1 and Be2 B cells are transcriptionally distinct 8.81
mTORC1 balances cellular amino acid supply with demand for protein synthesis through post-transcriptional control of ATF4 8.78
Gene expression profile using RNA-seq in WC00060 or SR-0788 cells transfected with siRNA for KPC1 or control 8.77
RNA sequencing of mechanically strained NHEKs and control NHEKs 8.77
RRAD, IL4I1, CDKN1A, and SERPINE1 genes are potentially co-regulated by NF-κB and p53 transcription factors in cells exposed to high doses of ionizing radiation [RNA-Seq] 8.74
Global response to chemotherapy-induced apoptosis 8.73
Disease Model of GATA4 Mutation Reveals Transcription Factor Cooperativity in Human Cardiogenesis 8.7
Disease Model of GATA4 Mutation Reveals Transcription Factor Cooperativity in Human Cardiogenesis [RNA-Seq] 8.7
BET bromodomain proteins function as master transcription elongation factors independent of CDK9 recruitment [NET-seq] 8.69
Paclitaxel plus Cirmtuzumab Achieves Greater Clearance of Patient-derived Xenografts By Targeting ROR1+ Breast Cancer Stem Cells 8.67
Bromodomain inhibition of the co-activators CBP/EP300 facilitates reprogramming (RNA-seq fibroblasts) 8.66
Bromodomain inhibition of the co-activators CBP/EP300 facilitates reprogramming 8.66
The effect of doxycycline-induced expression of host-cell-factor 2 (HCF-2) proteins on the global gene expression in HEK-293 cells 8.55
Transcriptomes of oxLDL exposed trained monocytes 8.52
oxLDL exposed trained monocytes 8.52
A recessive form of hyper-IgE syndrome by disruption of ZNF341-dependent STAT3 transcription and activity 8.51
Effect of TUNAR silencing and GSK3 inhibition on human b-cell transcriptome 8.51
Prostate Cancer Cell RNA-Seq (PC3E and GS689.Li) 8.42
RNA sequencing (RNA-SEQ) of Human endothelial cells (HUVEC) in LFS, sFRP2OE, and WT conditioned media 8.41
IL-6/Stat3-Dependent Induction of Distinct, Obesity-Associated Natural Killer Cells Deteriorates Energy and Glucose Homeostasis 8.41
RNA editing in nascent RNA affects pre-mRNA splicing 8.38
Indoxyl sulfate stimulates angiogenesis by regulating reactive oxygen species production via CYP1B1 8.35
The LINC01138 Drives Malignancies via Activating Arginine Methyltransferase 5 in Hepatocellular Carcinoma 8.32
ATF4 inhibition by p62 represses stromal metabolic reprogramming and tumorigenesis II 8.31
The ribonuclease activity of SAMHD1 is required for HIV-1 restriction 8.29
Solid phase chemistry to covalently and reversibly capture thiolated RNA 8.29
Total RNAseq of human putamen and caudate nucleus tissues in healthy control and Bipolar Disorder individuals 8.29
RNA deep sequencing to compare genome-wide differences between PRMT5/knockdown and control AML cells 8.25
RNA-seq in SUNE-1 cells after downregulation of DANCR expression 8.2
Simultaneous profiling of sexually transmitted bacterial pathogens, microbiome, and concordant host response in cervical samples using whole transcriptome sequencing analysis 8.2
The anti-leukemic effect of R-2HG depends on its acting as an m6A mRNA modifier-RNA Seq-PBS / R-2HG treatment 8.2
Distinct and shared functions of ALS-associated TDP-43, FUS, and TAF15 revealed by comprehensive multi-system integrative analyses [RNA-Seq_human] 8.05
Effects of rFVIIIFc on human macrophages 8.03
RNA-Sequencing data of Varicella Zoster Virus (VZV)-infected human dermal fibroblasts (HDF) 7.98
RNA-Seq Samples of siTFE3 in 8988T PDA Cell Line to Investigate Transcriptional Control of the Autophagy-Lysosome System 7.92
Human blood CD1c⁺ dendritic cells encompass CD5-high and CD5-low subsets that differ significantly in phenotype, gene expression and functions 7.9
Zika virus antagonizes interferon response in patients and disrupts RIG-I-MAVS interaction through its CARD-TM domains 7.86
LED, a long non-coding RNA activator of enhancer RNAs, is hypermethylated in human cancers 7.85
Mutational landscape of splicing genes and functional consequences across 33 cancer types 7.84
Next generation sequencing of human hepatic stellate cell line, LX-2 treated with recombinant human TGF-β1, with DMSO or ML290 (5 µM) for 72h. 7.8
Differential expression of pancreatic cancer PANC1 cells treated with pilocarpine 7.78
An alternative CTCF isoform antagonizes canonical CTCF occupancy and changes chromatin architecture to promote apoptosis 7.77
Region-specific Innate Antiviral Responses of the Human Epididymis 7.74
Effects of a nutritional supplement in older individuals subject to ten days of complete bed rest. 7.7
Transcriptome analysis of total RNA in human osteosarcoma cell line U2OS before and after inhibition of zinc finger protein ZNF768 7.65
Identification of differentially expressed genes between senescence and senescence bypass cells 7.6
Insulin receptor associates with promoters genome-wide and regulates gene expression [RNA-seq 2] 7.58
The RNA exosome nuclease complex regulates human embryonic stem cell differentiation [RNA-Seq SS] 7.58
Comparison between THP-1 cells obtained from either ATCC or DSMZ biorepository 7.56
RNAseq transcriptome analysis of White Blood Cells (WBCs) from individuals with and without trisomy 21 7.56
Dissection of estrogen receptor alpha signaling pathways in osteoblasts using RNA-sequencing 7.55
A NIK-SIX signaling axis controls inflammation by targeted silencing of noncanonical NF-κB 7.53
Effect of BCL11B overexpression on transcriptome of T-cell acute lymphoblastic leukemia (T-ALL) cells 7.51
The antineoplastic drug, trastuzumab, dysregulates metabolism in iPSC derived cardiomyocytes. 7.42
Immunophenotyping and Transcriptomic Outcomes in PDX-Derived TNBC Tissue 7.39
RNA deep sequencing analysis of glioma stem cells(GSCs) and non-GSCs 7.37
High-throughput RNA sequencing on circular RNA profiles of human bladder cancer tissues and normal bladder tissues 7.32
Unique features and clinical importance of acute alloreactive immune responses 7.28
FOXD3 is a novel tumor suppressor in lung cancer 7.26
Analyzing the interactions of mRNAs, miRNAs, lncRNAs and circRNAs to predict competing endogenous RNA networks in glioblastoma 7.24
Acetylation of spliceosome protein PHF5A modulates stress responses and colorectal carcinogenesis through alternative splicing mediated upregulation of KDM3A 7.2
Nucleotide stress induction of HEXIM1 suppresses melanoma by modulating cancer cell-specific gene transcription [RNA-Seq2] 7.18
LSD1 mediates AKT activity in PIK3CA mutant colorectal cancer 7.18
LSD1 mediates AKT activity in PIK3CA mutant colorectal cancer [RNA-Seq] 7.18
6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 4 is essential for p53-null cancer cells 7.05
K562 polyA RNA-Seq 7.03
Neutrophils in systemic onset Juvenile Idiopathic Arthritis display sepsis-like features which can be reverted by IL-1 blockade 7.03
Human CD4+CD103+ cutaneous resident memory T cells are found in the circulation of healthy subjects 7.0
KDM1A confers invasive and metastatic attributes in lung adenocarcinoma by modulating a non-canonical Integrin ß3-KRAS signaling pathway 6.99
Genome-wide expression profiling of B Lymphocytes reveals IL4R increase in allergic asthma 6.93
Defective structural RNA processing in relapsing-remitting multiple sclerosis 6.93
Single cell analysis of smooth muscle cell phenotypic modulation in vivo during disease in mice and humans 6.9
Single cell analysis of smooth muscle cell phenotypic modulation in vivo during disease in mice and humans [human scRNA-seq] 6.9
Nickel induced transcriptional changes persist post exposure through epigenetic reprograming (RNA-seq dataset) 6.89
Transcriptome profiling of HepG2 cells upon treatment of the menin-MLL inhibitor MI-503 or DMSO 6.86
Pancreatic cancer-derived exosomes induce apoptosis of T lymphocytes through the p38 MAPK signal transduction pathway 6.85
KLF4 as a rheostat of osteolysis and osteogenesis in prostate tumors in the bone 6.85
Modulation of SF3B1 causes global intron retention and downregulation of the B-cell receptor pathway in chronic lymphocytic leukemia 6.81
BET bromodomain inhibition 6.81
Effect of BET bromodomain inhibition with JQ1 in stressed human derived iPS cardiomyocytes 6.81
Gene expression profiles in NORAD knockout and PUMILIO overexpressing cells 6.78
Derivation of kidney organoids from human pluripotent stem cells [RNA-Seq: Data Set 2] 6.76
Analysis of Th17 gene signature in the presence of CD28 costimulation in human CD4 naïve T cells 6.73
Regulation of hypoxia-inducible factor activity by ZMYND8 6.66
Androgen receptor functions as transcriptional repressor of Cancer Associated Fibroblast (CAF) activation 6.63
Androgen receptor functions as transcriptional repressor of Cancer Associated Fibroblast (CAF) activation [RNA-seq] 6.63
Structural basis for human respiratory syncytial virus NS1-mediated modulation of host responses 6.62
RNA-Seq of CD4+ T cells treated with AS1842856 or DMSO 6.6
Precise Gene Editing Preserves Hematopoietic Stem Cell Function Following Transient p53-Mediate DNA Damage Response [bulk RNA-seq] 6.52
The Polycomb protein BMI1 induces an invasive gene expression signature in melanoma that promotes metastasis and chemoresistance. 6.52
Gene expression changes in HSV-1 infected HeLa cells with knockdown of B2M 6.51
TimeLapse-seq: adding a temporal dimension to RNA sequencing through nucleoside recoding 6.48
Cooperation of GRSF1 and the mitochondrial degradosome (hSuv3-PNPase complex) in degradation of mitochondrial RNA 6.44
A compendium of promoter-centered long-range chromatin interactions in diverse human tissues and cell types 6.39
Splicing and epigenetic factors jointly regulate epidermal differentiation 6.38
Next Generation Sequencing upon siRNA-mediated knockdown of DRAIC in MCF-7 cells. 6.37
RNA-Seq analysis of cSCC cells after siRNA-induced gene knockdown of lncRNA PRECSIT 6.35
Gene expressions of H9s in different culture systems 6.25
Expression of MERTK based on Multiple Sclerosis (MS) risk haplotype 6.21
Hypoxic transcriptome of SQ20B human head and neck cancer cells 6.19
PRMT5 Interacts with the BCL6 Oncoprotein and is Required for Germinal Center Formation and Lymphoma Cell Survival 6.13
Systematic Functional Dissection of Common Genetic Variation Affecting Red Blood Cell Traits [mRNA-Seq] 6.03
Systematic Functional Dissection of Common Genetic Variation Affecting Red Blood Cell Traits 6.03
Comparative total RNA and mRNA sequencing and systems analysis reveals nascent transcriptional response to early HIV-1 infection in a CD4+ T cell line 5.98
Transcriptomic profiles of human foreskin fibroblast cells in response to orf virus 5.96
Gene expression profile in breast cancer cells 5.95
Genome-wide profile of cJun and p27 and gene expression profile in breast cancer cells 5.95
Dysregulated immune system networks in war veterans with PTSD 5.79
Profiling of lung tumor-infiltrating CD8 T cells according to their expression status of CD39 5.79
Genome-wide analysis of YAP and TFCP2 down-regulated genes in liver cancer cells 5.79
Genome-wide analysis of YAP and TFCP2 occupancy and regulated expression in liver cancer cells 5.79
XBP1s Activation Globally Remodels N-Glycan Structure Distribution Patterns 5.75
MYCL and EP400 are required for Max and MCPyV mediated gene activation 5.62
Co-Stimulation–Induced AP-1 Activity is Required for Chromatin Opening During T Cell Activation. 5.59
Co-Stimulation–Induced AP-1 Activity is Required for Chromatin Opening During T Cell Activation [RNA-seq] 5.59
Human TFIIH kinase CDK7 regulates transcription-associated epigenetic modification 5.55
DDX54 regulates transcriptome dynamics during DNA damage response [4SU-seq] 5.55
Transcriptome analysis of VCaP xenografts resistant to dual therapy with abiraterone and enzalutamide 5.53
BBBomics - Human Blood Brain Barrier Transcriptomics Hub 5.47
BBBomics - Human Blood Brain Barrier Transcriptomics Hub [RNA-seq] 5.47
Microprocessor mediates transcription termination in long noncoding microRNA genes 5.45
RNA G-quadruplexes mark repressive upstream open reading frames in human mRNAs 5.44
Unbiased evaluation of cell-free amniotic fluid transcriptome of term and preterm infants to detect fetal maturity 5.38
Time-course expression data from HEK293∆RAF1:ER cells stimulated with 4OHT, U0126, CYHX, ActD, EGF, FGF, or IGF and labelled with 4SU 5.38
Time-course expression data from HEK293∆RAF1:ER cells stimulated with 4OHT and labelled with 4SU 5.38
Transcriptional response of human endocervical epithelial A2EN cells to infection with wild-type or CpoS-deficient Chlamydia trachomatis L2/434/Bu 5.26
Treatment of prostate cancer cells with S-adenosylmethionine leads to genomewide alterations of transcription profiles 5.19
Comparative genome-wide analysis of human BM IL3Rα-high precursors show a more MΦ-, DC- and OC committed gene expression profile, as compared to IL3Rα-low precursors 5.15
Global Long Terminal Repeat activation participates in establishing the unique gene expression program of classical Hodgkin Lymphoma [Primary RNA-Seq] 5.15
RNA-Sequencing of HUVEC treated with Tie2 activating antibody 5.08
LINE-2 transposable elements are a source of functional human microRNAs and target sites 5.06
Identification of altered developmental pathways in human juvenile HD iPSC with 71Q and 109Q using transcriptome profiling 5.03
Identification of PRMT5-dependent genes in ESA+CD24lowCD44+ MCF7 cells 4.99
Allergen-specific immunotherapy modulates the balance of circulating Tfh and Tfr cells 4.98
Endothelial gene expression analysis 4.95
Total RNA deep sequencing (ribosomal depleted) of human umbilical vein endothelial cells exposed to hypoxia (0.2%) for 12h and 24h or kept under normoxic conditions. 4.95
RNA deep sequencing analysis of human brain microvascular endothelial cells (ECs) treated with glioma-conditioned medium (glioma-CM) 4.93
RNA-sequencing 4.92
Regulation of stem cell property and drug resistance of cancer cells by targeting transcriptional machinery via inhibition of neddylation 4.87
Fra-1 is a key driver of colon cancer metastasis and a Fra-1 classifier predicts disease-free survival 4.85
RNA-seq and Hi-C sequencing of neutrophil-like cells migrated through large or small pores 4.82
Migration through a small pore disrupts inactive chromatin organisation in neutrophil-like cells [RNA-seq] 4.82
Transcriptome splicing analysis in K562 cells expressing rare and private spliceosomal mutations 4.81
CXCR4 is a host factor that regulates Plasmodium development in hepatocytes 4.76
Expression data from miR340 overexpressing human A549 cells 4.66
RNA-sequencing in irradiated and normal A549 cells. 4.64
ZNF599 and DNMT3A coordinately control nuclear envelope organization by repression of SUN4 expression 4.59
RNA Sequencing of three pairs of gastric cancer 4.58
Sequencing of freshly produced RNA following exposure of cells to DNA damage-inducing UV mimetic 4-hydroxyaminoquinolone (4-NQO) 4.5
Interaction between mitoNEET and NAF-1 in cancer cells 4.44
Polarized B -cell functions 4.31
DNA Methylation Reprograms Metabolic Gene Expression in End-Stage Human Heart Failure 4.25
TCR and inflammatory signals tune human MAIT cells to exert specific tissue repair and effector functions 4.23
RNA sequencing of human mammary epithelial cells 4.21
Reprogramming of dermal papilla cell intact gene signature with 3D culture and Lef-1 overexpression 4.17
Codon usage optimization in pluripotent embryonic stem cells [tRNA sequencing] 4.16
Global gene expression analysis of human monocyte-derived dendritic cells (DCs) treated with HMGN1 (N1) and R848 alone or in combination. 4.1
Identification of ADAR1 adenosine deaminase dependency in a subset of cancer cells 4.08
ChIPseq and RNAseq analysis of T47D cells with/without silencing TRPS1/CHD4 4.03
Glioma-derived miRNA-containing extracellular vesicles induce angiogenesis by reprogramming brain endothelial cells 4.01
Glioma-derived miRNA-containing extracellular vesicles induce angiogenesis by reprogramming brain endothelial cells (longRNA-seq) 4.01
lncRNA expression analysis in patients with eosinophilic and neutrophilic asthma 3.95
RNA Sequencing of Human iPS derived Cardiomyocytes 3.89
TGF-b-activated LncRNA LINC00115 is a critical regulator for glioma stem-like cell tumorigenicity 3.86
Sensing self and nonself circular RNAs 3.77
TWIST1-induced microRNA-424 drives an intermediate epithelial-to-mesenchymal transition that opposes metastasis 3.75
RNA-seq after siRNA targeting DDX24 applied to iHUVECs cell lines 3.68
Newly defined ABCB5+ dermal mesenchymal stem cells promote healing of chronic iron overload wounds via secretion of interleukin-1 receptor antagonist 3.67
Epigenomes and transcriptomes of human monocytes before and after in vivo exposure to Bacillus Calmette-Guérin vaccine 3.65
RNA sequencing of CACO-2 cells incubated with Bifidobacteria breve grown on human milk oligosaccharides. 3.62
RNA-sequencing analysis of glucose and acetate regulated transcripts in glioblastoma cells 3.62
AKAP8 inhibits tumor metastasis by antagonizing EMT-associated RNA alternative splicing 3.6
RNA-seq data 3.51
Role of COP1 on MAP kinase transcriptional output in melanoma 3.5
Ribosome profiling of TGFb-treated cells indicates reduced leucine availability 3.46
RNA sequencing of 13 T-cell acute lymphoblastic leukemia patients (5 TCRAD-MYC translocated T-ALL_8TAL1-LMO2 T-ALL) 3.43
Post-transcriptional remodelling is temporally deregulated during motor neurogenesis in human ALS models 3.43
Time-dependent regulation of cellular programming of monocytes by NCOR2 [RNASeq_KD] 3.38
quanTIseq: quantifying immune contexture of human tumors 3.36
RNAseq of CD8+ and CD8- MAIT cells in human peripheral blood 3.27
Gene expression analysis of human hepatocellular cancers 3.25
Transcriptome analysis of peripheral blood monocytes 3.2
Genetic regulation of human adipose microRNA expression and its consequences for metabolic traits 3.18
A systematic analysis of nuclear heat-shock protein 90 identifies a metazoan-specific regulatory module 3.18
Investigation about Monocytes in metastatic breast cancer patients under chemotherapy +/- Avastin 3.17
Long noncoding RNA signatures induced by TLR7 and type I IFN signaling in activated human plasmacytoid dendritic cells 3.15
Argonaute proteins couple chromatin silencing to alternative splicing 3.1
Argonaute proteins couple chromatin silencing to alternative splicing (RNA IP-Seq) 3.1
Histone Demethylases KDM3A and KDM4C regulate mesenchymal stromal cell senescence and bone aging through condensin-mediated heterochromatin organization 3.05
The novel lncRNA lnc-NR2F1 is pro-neurogenic and mutated in human neurodevelopmental disorders [lnc-Nr2f1 overexpression] 3.02
The novel lncRNA lnc-NR2F1 is pro-neurogenic and mutated in human neurodevelopmental disorders 3.02
RNA-Seq of human induced pluripotent stem cell-derived cardiomyocytes from a cardiomyopathy patient and familial control 2.99
RNA-SEQ assay for wild type and CRISPR induced endoglin knockout human pulmonary artery smooth muscle cells (PASMC) 2.99
IL-10 dysregulation in acute mountain sickness revealed by transcriptome analysis 2.93
MiR-CLIP capture of a miRNA targetome uncovers a lincRNA H19-miR-106a interaction [III] 2.91
Organelle-based therapy for immune mediated disease: mitochondrial transfer elicits Tregs reprogramming 2.89
RNA-Seq of PRMT1 overexpression ECA109 cells 2.86
UPF1/SMG7-dependent MicroRNA-mediated Gene Regulation 2.82
Pro-angiogenic Ginsenoside F1 and Rh1 Inhibit Vascular Leakage by Modulating NR4A1 2.75
RNA-seq transcriptonal profiling in human K562 cells with or without dCas9 and sgRNAs 2.74
In situ CAPTURE of chromatin interactions by biotinylated dCas9 2.74
Whole transcriptome sequencing identifies increased CXCR2 expression in PNH granulocytes 2.73
Molecular mechanism underlying increased ischemic damage in the ALDH2*2 genetic polymorphism using a human iPSC model system 2.72
Transcriptomic analysis of ERR alpha orphan nuclear receptor 2.65
Chromatin mapping and single-cell immune profiling defines the temporal dynamics of ibrutinib drug response in chronic lymphocytic leukemia 2.63
Chromatin mapping and single-cell immune profiling defines the temporal dynamics of ibrutinib drug response in chronic lymphocytic leukemia [scRNA-seq] 2.63
Measuring the effect of MYC on transcription during the DNA double-strand break response by RNA-seq of newly synthesized transcripts 2.62
RNA-seq analysis upon ARID1B overexpression 2.48
RNAseq transcriptome analysis of White Blood Cells (WBCs) from individuals with and without trisomy 21 [stranded] 2.48
Transcriptome of human ILC2s; primary vs IL-1b-primed 2.43
Epigenome-wide analysis of DNA methylation in lung tissue shows concordance with blood studies and identifies tobacco smoke-inducible enhancers 2.41
Kinetics of cytokine receptor trafficking determine signaling and functional selectivity 2.37
RNA expression profiles from HUVECs overexpressing adenovirally delivered HIF1a and HIF2a proteins 2.37
The transcriptomic landscape of MAIT cell development in the thymus (NN41 RNAseq data set) 2.31
HMGA1 and FOXM1 synergistically regulate a common gene network modulating angiogenesis in breast cancer 2.28
Distinct Pathological Signatures in Human Cellular Models of Myotonic Dystrophy Subtypes 2.27
Comprehensive RNA-Seq profiling in PBMCs of ALS patients and healthy controls 2.24
RNA-Seq profiling in PBMCs and spinal cord from ALS patients and healthy controls 2.24
polyA RNA Sequencing Analysis of HTR-8/SVneo cells after lnc-SLC4A1-1 overexpression 2.24
Expression analysis of PC3 cells treated with scramble AON or AON directed against MBNL1 2.2
Epithelial-mesenchymal transition markers screenedina cell-based model and validated in lung adenocarcinoma 2.14
Gene expression profile of differentially recognized Mtb-epitopes as a function of disease history 2.1
UV_24h_GRO-Seq 2.07
EPCR Expression Defines the Most Primitive Subset of Human HSPC and Is Required for Their In Vivo Activity 2.01
Identification of trans regulators of ADAR and A-to-I RNA editing using RNA-seq 1.98
Unbiased identification of trans regulators of ADAR and A-to-I RNA editing 1.98
RNA-seq analysis of control and Myc-induced U2OS cells 1.93
DHX36 resolves G-rich structures in mRNA untranslated region to allow their translation 1.89
Global Transcriptome Analysis and Enhancer Landscape of Human Primary T Follicular Helper and T Effector Lymphocytes (RNA-Seq) 1.88
Global Transcriptome Analysis and Enhancer Landscape of Human Primary T Follicular Helper and T Effector Lymphocytes 1.88
Study of dynamic transcriptome profiling in DNA damage-induced cellular senescence and transient cell-cycle arrest 1.83
RNA-Seq in human T-cell lymphoblastic lymphoma samples and control thymuses 1.82
Human T-cell lymphoblastic lymphoma samples and control thymuses 1.82
Noncoding regions are the main source of targetable tumor-specific antigens 1.79
Interferon-beta-inducible genes in human monocyte-derived macrophages (MDMs) 1.78
Analysis of gene expression in SKOV3 ovarian cancer cells after knockdown of the long non-coding RNA DNM3OS 1.73
Gene expression from AsPC-1 cells treated with PTC596 and DMSO 1.7
Functional Inflammatory Profiles Distinguish Myelin-Reactive T Cells from Patients with Multiple Sclerosis 1.7
Altered mRNA splicing by mutant p53 activates oncogenic RAS in pancreatic cancer 1.69
HMGA2 Promotes Long-Term Engraftment and Myelo-Erythroid Differentiation of Human Hematopoietic Stem and Progenitor Cells 1.66
miR-126 Orchestrates an Oncogenic Program in B-Cell Precursor Acute Lymphoblastic Leukemia 1.62
Sirt6 Oncogene Mediates PI3K/Akt Signaling Activation in Diffuse Large B-Cell Lymphoma 1.56
Enhancer Activation Requires Trans-Recruitment of a Mega Transcription Factor Complex 1.55
Enhancer Activation Requires Trans-Recruitment of a Mega Transcription Factor Complex (Gro-seq) 1.55
Transcriptome analysis of Riociguat and Vehicle control treatment in human hematopoietic stem and progenitor cells 1.55
Anti-inflammatory effect of indoleacrylic acid (IA) 1.5
Prolyl Hydroxylase Substrate Adenylosuccinate Lyase Is An Oncogenic Driver In Triple Negative Breast Cancer 1.46
Expression profile of MM.1S tumors folloiwing treatment with bortezomib 1.42
Next Generation Sequencing upon siRNA-mediated knockdown of EIF5A in MCF-7 cells. 1.41
An evolutionary recent IFN-IL-6-CEBP axis is linked to monocyte expansion and tuberculosis severity in humans. 1.41
RNA-Seq of CD34+ Bone Marrow Progenitors from Healthy Donors 1.32
Gene expression and chromatin organization changes in lamin A/C haploinsufficient human induced pluripotent stem cell-derived cardiomyocytes 1.26
Gene expression and chromatin organization changes in lamin A/C haploinsufficient human induced pluripotent stem cell-derived cardiomyocytes [RNA-seq] 1.26
RNA-seq analysis of umbilical cord blood cells upon knockdown of NAP1L3 1.24
Splicing and gene expression changes in human mammary epithelial MCF-10A cells expressing SR or SR-like proteins 1.19
Transcriptome sequencing wide functional analysis of human mesenchymal stem cells (Poly(I:C) and LPS) 1.15
Functional separation of IL7Rα/KLRG1-defined CD8+ T cell populations in humans 1.12
Expression of long non-coding RNAs in autoimmunity and linkage to enhancer function and autoimmune disease risk genetic variants 1.08
The transcription and translation landscapes during human cytomegalovirus infection reveal novel host-pathogen interactions 1.06
ELAVL2-regulated transcriptional networks in human neurons link atlernative splicing, autism and human neocortical evolution 1.02
Evolutionary origin and functional divergence of stem cell homeobox genes in eutherian mammals 1.01
RNA seq comparison between scrambled and shGRP78 cells 0.99
Viral shRNA Knockdown of INS Promotor Activity in EndoC-βH1 Cells  0.97
4C-seq of insulin promoter, knockdown of INS promoter activity and Genome-wide maps of chromatin state in EndoC-βH1 Cells 0.97
Peripheral whole blood mRNAs and lncRNAs expression analysis in eosinophilic asthmatics 0.96
Exploring the gene expression profile upon FXR1 knockdown in H358 cells using RNA-seq 0.94
The role of antigen presenting cells in the induction of HIV-1 latency in resting CD4+ T-cells 0.86
Tri-mannose grafting of chitosan nanocarriers remodels the macrophage response to bacterial infection 0.85
RNA-sequencing of the brain transcriptome implicates dysregulation of neuroplasticity, circadian rhythms, and GTPase binding in bipolar disorder 0.85
Transcriptional repression in hypoxia is mediated by the Sin3A histone deacetylase complex [RNA-seq] 0.82
A toxicogenomics approach to screen chlorinated flame retardants tris(2-chloroethyl) phosphate and tris(2-chloroisopropyl) phosphate for potential health effects 0.78
Role of COP1 on MAP kinase transcriptional output in gastrointestinal stromal tumor 0.76
Temporal comparison of transcriptomic alterations in human, mouse and rat primary B lymphocytes exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) 0.76
Gene Expression Analysis of HUVEC Seeded rBEL Contructs at Low and High Phases of Glucose Consumption 0.71
Dilated cardiomyopathy vs Myocarditis 0.63
Effects of transcription on genome - nuclear lamina interactions 0.61
Effects of transcription on genome - nuclear lamina interactions: RNA-seq data 0.61
Arnica montana stimulates extracellular matrix gene expression in human macrophages differentiated to wound-healing phenotype. 0.58
Determining mRNA half-lives on a transcriptome-wide scale 0.57
12hr 5-FU treatment vs. DMSO in SJSA cells (from 'A kinase independent role for CDK19 in p53 response') 0.54
A transcriptome dataset revealing the molecular features of breast cancer stem cells 0.5
Transcriptome-wide response to synthetic chromatin protein PcTF 0.47
Low-dose decitabine priming endows CAR T cells with enhanced and persistent anti-tumor potential by epigenetic reprogramming 0.46
RNA seq analysis of human macrophages after treatment of glimepiride versus empagliflozin. 0.45
The role of the Calcium-Sensing receptor in colorectal cancer 0.35
YY1 haploinsufficiency causes an intellectual disability syndrome featuring transcriptional and chromatin dysfunction. 0.33
YY1 haploinsufficiency causes an intellectual disability syndrome featuring transcriptional and chromatin dysfunction [RNA-seq] 0.33
RNA sequencing of bone marrow CD34+ cells from myelodysplastic syndrome patients with and without SF3B1 mutation and from healthy controls 0.28
RNA-Seq of SLNCR1 over-expression in the melanoma cell line A375 0.27
Single-cell Transcriptomic Atlas of the Human Retina Identifies Cell Types Associated with Age-Related Macular Degeneration [Microfluidics] 0.24
Transcriptome-wide off-target RNA editing induced by CRISPR-guided DNA base editors [Modifications - screen] 0.23
Transcriptomic analysis of the role of the integrin a6b4 in detached cells 0.21
m6A-dependent regulation of messenger RNA stability 0.11
Genome-wide profiling of cervical RNA-binding proteins identified HPV regulation of RNASEH2A expression by viral E7 and E2F1 0.11
Hsa-miR-139-5p/HNRNPF axis modulates gene-transcripts balance in thyroid cancer cells 0.1
Transcriptomic Alterations in Lung Adenocarcinoma Unveil New Mechanisms Targeted by the TBX2 Subfamily of Tumor Suppressor Genes 0.09
Targets mediated microRNA arm-imbalance promotes gastric cancer progression [lncRNA] 0.09
Hyper-activation of HUSH complex function by Charcot-Marie-Tooth disease mutation in MORC2 0.04
A code of mono-phosphorylation modulates the function of RB. 0.04


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation